175 related articles for article (PubMed ID: 25890201)
1. mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer.
Shahbaz M; Ruliang F; Xu Z; Benjia L; Cong W; Zhaobin H; Jun N
World J Surg Oncol; 2015 Feb; 13():46. PubMed ID: 25890201
[TBL] [Abstract][Full Text] [Related]
2. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR.
Li M; Li W; Kim HJ; Yao Q; Chen C; Fisher WE
J Surg Res; 2004 Jun; 119(2):130-7. PubMed ID: 15145694
[TBL] [Abstract][Full Text] [Related]
3. Gene Expression of Col11A1 Is a Marker Not only for Pancreas Carcinoma But also for Adenocarcinoma of the Papilla of Vater, Discriminating Between Carcinoma and Chronic Pancreatitis.
Kleinert R; Prenzel K; Stoecklein N; Alakus H; Bollschweiler E; Hölscher A; Warnecke-Eberz U
Anticancer Res; 2015 Nov; 35(11):6153-8. PubMed ID: 26504042
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma.
Gandhi AV; Saxena S; Relles D; Sarosiek K; Kang CY; Chipitsyna G; Sendecki JA; Yeo CJ; Arafat HA
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S636-43. PubMed ID: 23846787
[TBL] [Abstract][Full Text] [Related]
6. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
Papotti M; Bongiovanni M; Volante M; Allìa E; Landolfi S; Helboe L; Schindler M; Cole SL; Bussolati G
Virchows Arch; 2002 May; 440(5):461-75. PubMed ID: 12021920
[TBL] [Abstract][Full Text] [Related]
7. Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors.
Nakayama Y; Wada R; Yajima N; Hakamada K; Yagihashi S
Pancreas; 2010 Nov; 39(8):1147-54. PubMed ID: 20717067
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Sakai H; Fujita H; Nakata K; Tanaka M
Ann Surg Oncol; 2010 Dec; 17(12):3120-8. PubMed ID: 20652642
[TBL] [Abstract][Full Text] [Related]
9. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma.
Zhang JJ; Zhu Y; Zhu Y; Wu JL; Liang WB; Zhu R; Xu ZK; Du Q; Miao Y
Clin Transl Oncol; 2012 Feb; 14(2):116-24. PubMed ID: 22301400
[TBL] [Abstract][Full Text] [Related]
10. High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Wang L; Gu F; Liu CY; Wang RJ; Li J; Xu JY
Tumour Biol; 2013 Apr; 34(2):853-8. PubMed ID: 23242609
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.
Jonas S; John M; Boese-Landgraf J; Häring R; Prevost G; Thomas F; Rosewicz S; Riecken EO; Wiedenmann B; Neuhaus P
Langenbecks Arch Chir; 1995; 380(2):90-5. PubMed ID: 7760656
[TBL] [Abstract][Full Text] [Related]
12. Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.
Qin RY; Fang RL; Gupta MK; Liu ZR; Wang DY; Chang Q; Chen YB
World J Gastroenterol; 2004 Jan; 10(1):132-5. PubMed ID: 14695784
[TBL] [Abstract][Full Text] [Related]
13. Transfection of SSTR-1 and SSTR-2 inhibits Panc-1 cell proliferation and renders Panc-1 cells responsive to somatostatin analogue.
Li M; Zhang R; Li F; Wang H; Kim HJ; Becnel L; Yao Q; Chen C; Fisher WE
J Am Coll Surg; 2005 Oct; 201(4):571-8. PubMed ID: 16183496
[TBL] [Abstract][Full Text] [Related]
14. Expression of somatostatin receptor subtypes and growth inhibition in human exocrine pancreatic cancers.
Kikutsuji T; Harada M; Tashiro S; Ii S; Moritani M; Yamaoka T; Itakura M
J Hepatobiliary Pancreat Surg; 2000; 7(5):496-503. PubMed ID: 11180877
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype gene expression in pituitary adenomas.
Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
[TBL] [Abstract][Full Text] [Related]
17. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
[TBL] [Abstract][Full Text] [Related]
18. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo.
Nielsen S; Mellemkjaer S; Rasmussen LM; Ledet T; Olsen N; Bojsen-Møller M; Astrup J; Weeke J; Jørgensen JO
J Endocrinol Invest; 2001 Jun; 24(6):430-7. PubMed ID: 11434667
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of somatostatin receptor subtype-related genes and proteins in non-functioning and functioning adrenal cortex adenomas.
Pisarek H; Krupiński R; Kubiak R; Borkowska E; Pawlikowski M; Winczyk K
Mol Med Rep; 2011; 4(5):963-9. PubMed ID: 21720716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
